KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,955,150 | +50.6% | 112,559 | +22.0% | 0.00% | – |
Q2 2023 | $1,298,655 | -36.1% | 92,234 | -51.2% | 0.00% | – |
Q1 2023 | $2,033,844 | -39.5% | 189,019 | -15.8% | 0.00% | – |
Q4 2022 | $3,362,201 | +244.5% | 224,446 | +195.5% | 0.00% | – |
Q3 2022 | $976,000 | +295.1% | 75,948 | +197.0% | 0.00% | – |
Q2 2022 | $247,000 | -22.6% | 25,569 | -20.3% | 0.00% | – |
Q1 2022 | $319,000 | -79.4% | 32,062 | -75.6% | 0.00% | – |
Q4 2021 | $1,549,000 | +235.3% | 131,582 | +224.5% | 0.00% | – |
Q3 2021 | $462,000 | -2.5% | 40,552 | +19.2% | 0.00% | – |
Q2 2021 | $474,000 | -56.5% | 34,020 | -42.2% | 0.00% | – |
Q1 2021 | $1,090,000 | +135.9% | 58,872 | +125.1% | 0.00% | – |
Q4 2020 | $462,000 | -89.0% | 26,152 | -90.4% | 0.00% | -100.0% |
Q3 2020 | $4,186,000 | -36.9% | 273,204 | +4.8% | 0.00% | 0.0% |
Q2 2020 | $6,639,000 | +155.0% | 260,581 | +54.9% | 0.00% | – |
Q1 2020 | $2,604,000 | +51.4% | 168,191 | +8.2% | 0.00% | – |
Q4 2019 | $1,720,000 | +49.2% | 155,505 | +14.8% | 0.00% | – |
Q3 2019 | $1,153,000 | +852.9% | 135,512 | +1415.3% | 0.00% | – |
Q2 2019 | $121,000 | +63.5% | 8,943 | +118.7% | 0.00% | – |
Q1 2019 | $74,000 | -77.4% | 4,089 | -64.8% | 0.00% | – |
Q4 2018 | $327,000 | +1111.1% | 11,631 | +1021.6% | 0.00% | – |
Q3 2018 | $27,000 | – | 1,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |